CLEC2A antibody (N-Term)
Quick Overview for CLEC2A antibody (N-Term) (ABIN6991726)
Target
See all CLEC2A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- CLEC2A antibody is human specific. Two alternatively spliced transcript variants have been observed.
-
Purification
- CLEC2A Antibody is affinity chromatography purified via peptide column.
-
Immunogen
- CLEC2A antibody was raised against a 16 amino acid synthetic peptide near the amino terminus of human CLEC2A. The immunogen is located within the first 50 amino acids of CLEC2A.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
CLEC2A antibody can be used for detection of CLEC2A by Western blot at 1 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
Antibody validated: Western Blot in human samples and Immunofluorescence in human samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- CLEC2A Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- CLEC2A antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- CLEC2A (C-Type Lectin Domain Family 2, Member A (CLEC2A))
-
Alternative Name
- CLEC2A
-
Background
- CLEC2A Antibody: CLEC2A (C-type lectin domain family 2 member A), also known as PILAR (proliferation-induced lymphocyte-associated receptor) is involved in modulating T-cell expansion. It is a 32 kDa single-pass type II membrane protein that contains one C-type lectin domain in its extracellular region and belongs to the CTL/CTLD superfamily. CLEC2A is mainly expressed in skin and highly expressed in CD8(+), B lymphocytes and naive CD4(+) T cells. Manipulation of CLEC2A signaling may be important for treatment of autoimmune diseases and cancer.
-
Gene ID
- 387836
-
NCBI Accession
- NP_001124183
-
UniProt
- Q6UVW9
Target
-